“Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)”, Clinical Oncohematology, vol. 16, no. 2, pp. 227–228, Mar. 2023, doi: 10.21320/2500-2139-2023-16-2-resolution.